CD34 and acute myeloid leukemia: They were first described almost three decades ago in pioneering work by the Dick laboratory [3], where AML progenitors were shown to generate disease in SCID mice at low frequency, with enrichment of disease transfer demonstrated for transplantation of the primitive CD34+/CD38− fraction.